Primaquine to prevent transmission of falciparum malaria.
about
Primaquine or other 8-aminoquinoline for reducing Plasmodium falciparum transmissionPrimaquine or other 8-aminoquinoline for reducing P. falciparum transmission4(1H)-pyridone and 4(1H)-quinolone derivatives as antimalarials with erythrocytic, exoerythrocytic, and transmission blocking activitiesThe role of early detection and treatment in malaria eliminationPharmacokinetic and pharmacodynamic considerations in antimalarial dose optimizationReview of key knowledge gaps in glucose-6-phosphate dehydrogenase deficiency detection with regard to the safe clinical deployment of 8-aminoquinoline treatment regimens: a workshop reportMathematical Modelling to Guide Drug Development for Malaria EliminationGametocyte carriage in uncomplicated Plasmodium falciparum malaria following treatment with artemisinin combination therapy: a systematic review and meta-analysis of individual patient dataReview of mass drug administration for malaria and its operational challengesSustained efficacy of artesunate-sulfadoxine-pyrimethamine against Plasmodium falciparum in Yemen and a renewed call for an adjunct single dose primaquine to clear gametocytesQuality of antimalarial drugs and antibiotics in Papua New Guinea: a survey of the health facility supply chainEthics, economics, and the use of primaquine to reduce falciparum malaria transmission in asymptomatic populationsSingle Low Dose Primaquine (0.25 mg/kg) Does Not Cause Clinically Significant Haemolysis in G6PD Deficient SubjectsIvermectin to reduce malaria transmission III. Considerations regarding regulatory and policy pathways.Safety of 8-aminoquinolines given to people with G6PD deficiency: protocol for systematic review of prospective studies.Hundreds of dual-stage antimalarial molecules discovered by a functional gametocyte screenSingle dose primaquine to reduce gametocyte carriage and Plasmodium falciparum transmission in Cambodia: An open-label randomized trial.Molecular Markers for Sensitive Detection of Plasmodium falciparum Asexual Stage Parasites and their Application in a Malaria Clinical Trial.Glucose-6-phosphate dehydrogenase status and risk of hemolysis in Plasmodium falciparum-infected African children receiving single-dose primaquine.Sub-microscopic gametocyte carriage in febrile children living in different areas of Gabon.Primaquine: the risks and the benefitsAntimalarial activity of the myxobacterial macrolide chlorotonil a.Glucose-6-phosphate dehydrogenase deficiency among malaria suspects attending Gambella hospital, southwest Ethiopia.Assessment of therapeutic responses to gametocytocidal drugs in Plasmodium falciparum malariaIn vivo monitoring of dihydroartemisinin-piperaquine sensitivity in Plasmodium falciparum along the China-Myanmar border of Yunnan Province, China from 2007 to 2013Oral lipid-based nanoformulation of tafenoquine enhanced bioavailability and blood stage antimalarial efficacy and led to a reduction in human red blood cell loss in mice.Mass campaigns with antimalarial drugs: a modelling comparison of artemether-lumefantrine and DHA-piperaquine with and without primaquine as tools for malaria control and elimination.Imaging-based high-throughput screening assay to identify new molecules with transmission-blocking potential against Plasmodium falciparum female gamete formation.An assessment of the supply, programmatic use, and regulatory issues of single low-dose primaquine as a Plasmodium falciparum gametocytocide for sub-Saharan Africa.Malaria eradication and elimination: views on how to translate a vision into realityPlasmodium transmission blocking activities of Vernonia amygdalina extracts and isolated compounds.A semi-automated luminescence based standard membrane feeding assay identifies novel small molecules that inhibit transmission of malaria parasites by mosquitoes.Submicroscopic carriage of Plasmodium falciparum and Plasmodium vivax in a low endemic area in Ethiopia where no parasitaemia was detected by microscopy or rapid diagnostic test.Inclusion of gametocyte parameters in anti-malarial drug efficacy studies: filling a neglected gap needed for malaria eliminationIn Vitro Activities of Primaquine-Schizonticide Combinations on Asexual Blood Stages and Gametocytes of Plasmodium falciparumA multiplex method for detection of glucose-6-phosphate dehydrogenase (G6PD) gene mutations.Rationale for recommending a lower dose of primaquine as a Plasmodium falciparum gametocytocide in populations where G6PD deficiency is common.Dihydroartemisinin-piperaquine resistance in Plasmodium falciparum malaria in Cambodia: a multisite prospective cohort study.Predicting mosquito infection from Plasmodium falciparum gametocyte density and estimating the reservoir of infection.Glucose-6-phosphate dehydrogenase deficiency prevalence and genetic variants in malaria endemic areas of Colombia.
P2860
Q24188070-5615652C-E43C-48F2-B488-16464E7A269EQ24193716-7F885F96-78CE-4512-9B03-9CA6DD60FE34Q24757085-5E22D6FE-5A9A-4FDC-89CD-3B42FFE3AD67Q26740068-4BF71AC4-DC03-4667-A9A8-A885D0457C4BQ26830528-F15312DD-3916-459B-AB7F-DD6BA011F332Q27024922-4F084942-B8B0-45C3-A42B-EBEE4FC09692Q28067367-CE16819B-B8CB-45F6-B483-E560BBCDB026Q28068072-72014AF4-D7B5-4733-9EAD-089083536620Q28083426-6020467C-C790-47F7-9AF7-AF57C7BBE999Q28125936-DF71DD00-116D-488A-836F-0CBF85F9470DQ28538830-E2A8089B-D4A8-40FE-B832-F76FF6831A11Q28542069-A486FE6D-880B-4CD7-8118-7C8BE5411917Q28550990-13695C36-9B65-4CE2-9E4D-4BE512D6400DQ33593781-764E2468-1E75-456E-AB3F-26E5042B1461Q33626090-A1FF1FA7-B243-41B6-BA84-3FDE5D0D175BQ33720859-10E8A5C6-9E88-437A-A967-B55DFE02931AQ33772980-359FFBEC-E83C-4BB2-8F11-262D0DBB9DB0Q33901814-0708E834-5CCF-4194-84D4-E07786AAF4BDQ34058341-1D3CCC96-2F36-4B69-AF83-D7AA93CA7F2BQ34493765-0F5E48F8-10CC-4819-840D-977890E39E5FQ34503631-1D91322B-9E25-4552-B917-F29994E87449Q34596488-B2F00ABD-663E-4556-B679-FCBB366814A2Q34611917-E8559BFE-9A96-4F77-BBA0-FD9810978C24Q34968407-216CFD3F-B885-49D3-B4CE-BD60705802BFQ35099599-35795616-A64A-4244-BFDF-25030C15014BQ35136121-355717FE-DD3D-4858-B9D0-CE0DEEE6D208Q35224221-7EB74A6A-D51C-4312-821B-944D5361AB3BQ35584827-95AC7CFF-7890-4BB1-A3C0-04EFE01E13BBQ35655782-13550AD2-C682-4E76-900C-FD2389BFF42BQ35712522-C8E9F925-1E2F-4D4A-A315-76715D09F3A1Q35712615-0CFDC73C-2D0C-4EE5-A7E5-82C84432CF3BQ35873837-5DD63555-4AD2-480F-9E53-B8C38DDC7604Q35913794-527D1DBD-17E3-41F4-A182-1320F433F602Q36198846-B65A9CD0-BAF1-4396-A81A-0843D294452AQ36290632-26186B2E-56D9-4A1D-8405-4375D0054080Q36470723-B5C06D01-FDF5-44A7-89BE-AC3CCCEF0BBCQ36538990-584D951A-AB03-4BE2-AC87-898FAF144681Q36689509-DCB1A8CE-D89D-4534-8693-E8AD092A3F19Q36864852-DED8E682-376D-41DC-B204-357F2BF4E54DQ36937236-BDF86130-D6E1-48DE-B78F-8BAD6863F5F9
P2860
Primaquine to prevent transmission of falciparum malaria.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Primaquine to prevent transmission of falciparum malaria.
@en
Primaquine to prevent transmission of falciparum malaria.
@nl
type
label
Primaquine to prevent transmission of falciparum malaria.
@en
Primaquine to prevent transmission of falciparum malaria.
@nl
prefLabel
Primaquine to prevent transmission of falciparum malaria.
@en
Primaquine to prevent transmission of falciparum malaria.
@nl
P921
P1476
Primaquine to prevent transmission of falciparum malaria.
@en
P304
P356
10.1016/S1473-3099(12)70198-6
P577
2012-11-23T00:00:00Z